First meeting on bone quality, Abbaye des Vaux de Cernay, France, 15-16 June 2006: Bone architecture

Osteoporosis International

Volumn 18, Issue 6, 2007, Pages 837-889

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BONE BIOPSY; BONE DENSITY; BONE MASS; BONE RADIOGRAPHY; BONE REMODELING; BONE STRENGTH; BONE STRUCTURE; CAUSAL ATTRIBUTION; CONFERENCE PAPER; CORRELATION FUNCTION; DIAGNOSTIC IMAGING; DRUG EFFICACY; FRAGILITY FRACTURE; HUMAN; NORMAL DISTRIBUTION; OSTEOPOROSIS; PRIORITY JOURNAL; RISK ASSESSMENT; THREE DIMENSIONAL IMAGING; TRABECULAR BONE;

BONE AND BONES; BONE DENSITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; OSTEOPOROSIS;

EID: 34247647987     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-007-0366-4     Document Type: Conference Paper

References (21)

1. Müller R, van Lenthe GH (2004) Microarchitectural aspects of bone quality and competence of bone. Adv Osteoporotic Fract Manag 3:2-12
2. Boutroy S, Bouxsein ML, Munoz F, Delmas PD (2005) In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab 90:6508-6515
3. Khosla S, Melton LJ 3rd, Achenbach SJ, Oberg AL, Riggs BL (2006) Hormonal and biochemical determinants of trabecular microstructure at the ultradistal radius in women and men. J Clin Endocrinol Metab 91:885-91
4. Zouch B, Gerbay T, Thomas L, Vico C, Alexandre (2005) In vivo 3D architectural analysis showed differences in patients with Colle's and femoral neck fractures (ADOQ Study). J Bone Miner Res 20(Suppl1):S305
5. Borah B, Dufresne TE, Chmielewski PA, Gross GJ, Prenger MC, Phipps RJ (2002) Risedronate preserves trabecular architecture and increases bone strength in vertebra of ovariectomized minipigs as measured by three-dimensional microcomputed tomography. J Bone Miner Res 17:1139-1147
6. Barou O, Lafage-Proust MH, Martel C, Thomas T, Tirode F, Laroche N, Barbier A, Alexandre C, Vico L (1999) Bisphosphonate effects in rat unloaded hindlimb bone loss model: three-dimensional microcomputed tomographic, histomorphometric, and densitometric analyses. J Pharmacol Exp Ther 291:321-328
7. Ding M, Day JS, Burr DB, Mashiba T, Hirano T, Weinans H, Sumner DR, Hvid I (2003) Canine cancellous bone microarchitecture after one year of high-dose bisphosphonates. Calcif Tissue Int 72:737-744
8. Onoe Y, Miyaura C, Ito M, Ohta H, Nozawa S, Suda T (2000) Comparative effects of estrogen and raloxifene on B lymphopoiesis and bone loss induced by sex steroid deficiency in mice. J Bone Miner Res 15:541-549
9. Dufresne TE, Chmielewski PA, Manhart MD, Johnson TD, Borah B (2003) Risedronate preserves bone architecture in early postmenopausal women in 1 year as measured by three-dimensional microcomputed tomography. Calcif Tissue Int 73:423-432
10. Borah B, Dufresne TE, Chmielewski PA, Johnson TD, Chines A, Manhart MD (2004) Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography. Bone 34:736-46
11. Borah B, Dufresne TE, Ritman EL, Jorgensen SM, Liu S, Chmielewski PA, Phipps RJ, Zhou X, Sibonga JD, Turner RT (2006) Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: sequential triple biopsy studies with micro-computed tomography. Bone 39:345-352
12. Nuzzo S, Lafage-Proust MH, Martin-Badosa E, Boivin G, Thomas T, Alexandre C, Peyrin F (2002) Synchrotron radiation microtomography allows the analysis of three-dimensional microarchitecture and degree of mineralization of human iliac crest biopsy specimens: effects of etidronate treatment. J Bone Miner Res 17:1372-1382
13. Eastell R, Barton I, Hannon RA, Chines A, Garnero P, Delmas PD (2003) Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J Bone Miner Res 18:1051-1056
14. Kostenuik PJ, Paul C, Smith S, Asuncion F, Atkinson J (2004) The RANKL antagonist OPG-Fc causes significantly increases in cortical bone mineral area, content and density in adult cynomolgus monkeys. J Bone Miner Res 19(Suppl1):S19
15. Reeve J, Meunier PJ, Parsons JA, Bernat M, Bijvoet OL, Courpron P, Edouard C, Klenerman L, Neer RM, Renier JC, Slovik D, Vismans FJ, Potts JT Jr (1980) Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. Br Med J 280:1340-1344
16. Sato M, Westmore M, Ma YL, Schmidt A, Zeng QQ, Glass EV, Vahle J, Brommage R, Jerome CP, Turner CH (2004) Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity. J Bone Miner Res 19:623-629
17. Jerome CP, Burr DB, Van Bibber T, Hock JM, Brommage R (2001) Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis). Bone 28:150-159
18. Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF (2003) Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res 18:1932-1941
19. Zanchetta JR, Bogado CE, Ferretti JL, Wang O, Wilson MG, Sato M, Gaich GA, Dalsky GP, Myers SL (2003) Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis. J Bone Miner Res 18:539-543t
20. Bain S, Shen V, Zheng H, Liu C, Hara P, Dupin-Roger I (2003) Long-term treatment with strontium ranelate increases histomorphometry indices of bone formation in ovariectomized rats. J Bone Miner Res 18(suppl 2):S277
21. Ammann P, Shen V, Robin B, Mauras Y, Bonjour JP, Rizzoli R (2004) Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats. J Bone Miner Res 19:2012-2020